Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 72.00 | |
2 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 247.00 | |
25 mg | In stock | $ 486.00 | |
50 mg | In stock | $ 716.00 | |
100 mg | In stock | $ 987.00 |
Description | NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM). |
Targets&IC50 | MELK:6.01 μM, CK2:5.7 μM, Mps1:182 nM, NEK6:6.02 μM |
In vitro | NMS-P715 (1 μM) inhibits the proliferation of HCT116 cells. And it causes mitotic acceleration in U2OS cells overexpressing YFP-α-tubulin, induces aneuploidy. NMS-P715 (0.5, 1 μM) affects mitotic checkpoint complex (MCC) stability and cdc20 ubiquitylation[1]. |
In vivo | NMS-P715 (90 mg/kg, p.o.) is well tolerated and causes no signs of body weight loss or other overt toxicities in an A2780 ovary carcinoma xenograft model[1]. |
Molecular Weight | 676.73 |
Formula | C35H39F3N8O3 |
CAS No. | 1202055-32-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2 mg/mL (2.96 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NMS-P715 1202055-32-0 Cytoskeletal Signaling MAPK Metabolism PI3K/Akt/mTOR signaling Stem Cells MELK Casein Kinase Kinesin NMS-P 715 Monopolar spindle 1 Mps1 NMS P715 NMS-P-715 inhibit NMSP715 Inhibitor inhibitor